2 Safe-and-Steady Stocks with Solid Fundamentals and 1 We Question

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who ...

Zenas BioPharma Announces Positive Results from Phase 3 INDIGO Registrational Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD)

Obexelimab met the primary endpoint demonstrating a clinically meaningful and highly statistically significant 56% reduction in risk of IgG4-RD ...

Jade Biosciences Outlines Key 2026 Objectives and Strategy to Advance Pipeline of Potentially Best-in-Class Monoclonal Antibodies Across Multiple Autoimmune Diseases Ahead of ...

JADE101 Phase 1 healthy volunteer trial ongoing; biomarker-rich interim data expected in the first half of 2026 Phase 2 clinical trial of JADE101 ...

Power Variable Frequency Drive Market worth $7.08 billion by 2030 | MarketsandMarkets

According to MarketsandMarkets, The Power Variable Frequency Drive market is projected to reach USD 7.08 billion by 2030 from an estimated USD ...